The DOI matches its Crossref record; 154 of the 172 references it cites were found in a registry or an index, and 6 are not checked yet.
Molecular cell biology of androgen receptor signalling
Abstract
The classical action of androgen receptor (AR) is to regulate gene transcriptional processes via AR nuclear translocation, response element binding and recruitment of, or crosstalk with, transcription factors. AR also utilises non-classical, non-genomic mechanisms of signal transduction. These precede gene transcription or protein synthesis, and involve steroid-induced modulation of cytoplasmic or cell membrane-bound regulatory proteins. Despite many decades of investigation, the role of AR in gene regulation of cells and tissues remains only partially characterised. AR exerts most of its effects in sex hormone-dependent tissues of the body, but the receptor is also expressed in many tissues not previously thought to be androgen sensitive. Thus it is likely that a complex, more over-arching, role for AR exists. Each AR domain co-ordinates a multitude of individual and vital roles via a diverse array of interacting partner molecules that are necessary for cellular and tissue development and maintenance. Aberrant AR activity, promoted by mutations or binding partner misregulation, can present as many clinical manifestations including androgen insensitivity syndrome and prostate cancer. In the case of malignant prostate cancer, treatment generally revolves around androgen deprivation therapies designed to interfere with AR action and the androgen signalling axis. Androgen therapies for prostate cancer often fail, highlighting a real need for increased research into AR function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Androgen transmits signals via cell membrane receptors [19], which are distinct from the androgen nuclear receptors [20].”
From G protein-coupled receptors function as cell membrane receptors for the steroid hormone 20-hydroxyecdysone (2020) · cites this paper as [20]
Citations
Cites
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
Development of a second-generation antiandrogen for treatment of advanced prostate cancer.
Tran, C., Ouk, S., Clegg, N. J., Chen, Y., Watson, P. A., Arora, V., Wongvipat, J., Smith-Jones, P. M., Yoo, D., Kwon, A., et al. (2009) · Science · doi:10.1126/science.1168175 · Cited by 2,292
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Sreekumar, A., Poisson, L., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,269
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA
Luisi, B. F., Xu, W. X., Otwinowski, Z., Freedman, L. P., Yamamoto, K. R., & Sigler, P. B. (1991) · Nature · doi:10.1038/352497a0 · Cited by 1,503
Okamoto, T., Schlegel, A., Scherer, P. E., & Lisanti, M. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5419 · Cited by 1,496
Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups
Edwards, A., Hammond, H. A., Li, J., Caskey, C. T., & Chakraborty, R. (1992) · Genomics · doi:10.1016/0888-7543(92)90371-x · Cited by 1,426
Montgomery, R. B., Mostaghel, E. A., Vessella, R., Hess, D. L., Kalhorn, T. F., Higano, C. S., True, L. D., & Nelson, P. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0249 · Cited by 1,419
Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer
Taplin, M., Bubley, G. J., Shuster, T. D., Frantz, M. E., Spooner, A. E., Ogata, G. K., Keer, H. N., & Balk, S. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505253322101 · Cited by 1,243
Chamberlain, N. L., Driver, E. D., & Miesfeld, R. L. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.15.3181 · Cited by 1,149
Caveolae: From Cell Biology to Animal Physiology
Razani, B., Woodman, S. E., & Lisanti, M. P. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.431 · Cited by 983
Craft, N., Shostak, Y., Carey, M., & Sawyers, C. L. (1999) · Nature Medicine · doi:10.1038/6495 · Cited by 980
Molecular Biology of the Androgen Receptor
Gelmann, E. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.018 · Cited by 972
Determinants of target gene specificity for steroid/thyroid hormone receptors
Umesono, K., & Evans, R. M. (1989) · Cell · doi:10.1016/0092-8674(89)90051-2 · Cited by 948
Androgen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943
Attard, G., Reid, A. H. M., Yap, T. A., Raynaud, F., Dowsett, M., Settatree, S., Barrett, M., Parker, C., Martins, V., Folkerd, E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9749 · Cited by 903
A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis
Gendt, K. D., Swinnen, J. V., Saunders, P. T. K., Schoonjans, L., Dewerchin, M. A., Devos, A., Tan, K. A. L., Atanassova, N. N., Claessens, F., Lécureuil, C., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308114100 · Cited by 805
Orchestrated response: a symphony of transcription factors for gene controlPreprint
Lemon, B. D., & Tjian, R. (2000) · Genes & Development · doi:10.1101/gad.831000 · Cited by 762
Heemers, H. V., & Tindall, D. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0019 · Cited by 753
Locke, J. A., Guns, E. S., Lubik, A. A., Adomat, H. H., Hendy, S. C., Wood, C. A., Ettinger, S. L., Gleave, M. E., & Nelson, C. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5997 · Cited by 747
Thornton, J. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091553298 · Cited by 685
The Androgen Axis in Recurrent Prostate Cancer
Mohler, J. L., Gregory, C. W., Ford, O. H., Kim, D., Weaver, C. M., Petrusz, P., Wilson, E. M., & French, F. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1146-03 · Cited by 675
Wu, X., Senechal, K., Neshat, M. S., Whang, Y. E., & Sawyers, C. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15587 · Cited by 674
Formation of the Androgen Receptor Transcription Complex
Shang, Y., Myers, M., & Brown, M. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00471-9 · Cited by 673
Migliaccio, A., Castoria, G., Domenico, M. D., de Falco, A., Bilancio, A., Lombardi, M., Barone, M. V., Ametrano, D., Zannini, M. S., Abbondanza, C., et al. (2000) · The EMBO Journal · doi:10.1093/emboj/19.20.5406 · Cited by 672
Transcriptional activation and nuclear targeting signals of the human androgen receptor.
Simental, J. A., Sar, M., Lane, M. V., French, F. S., & Wilson, E. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52466-2 · Cited by 631
PKB/AKT: functional insights from genetic models
Scheid, M. P., & Woodgett, J. R. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096067 · Cited by 614
Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen Receptor
Matias, P. M., Donner, P., Coelho, R., Thomaz, M., Peixoto, C., Macedo, S., Otto, N., Joschko, S., Scholz, P., Wegg, A., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004571200 · Cited by 608
Attard, G., Reid, A. H. M., A'Hern, R., Parker, C., Oommen, N. B., Folkerd, E., Messiou, C., Molife, L. R., Maier, G., Thompson, E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.0642 · Cited by 605
Yeh, S., Lin, H., Kang, H., Thin, T. H., Lin, M., & Chang, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5458 · Cited by 594
Membrane microdomains and caveolae
Kurzchalia, T. V., & Parton, R. G. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80061-1 · Cited by 579
Gutman, A. B., & GUTMAN, E. B. (1938) · Journal of Clinical Investigation · doi:10.1172/jci100974 · Cited by 555
Jenster, G., van der Korput, H. A. G. M., van Vroonhoven, C., van der Kwast, T. H., Trapman, J., & Brinkmann, A. O. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-10-1396 · Cited by 523
Megestrol acetate for the prevention of hot flashes.
Loprinzi, C. L., Michalak, J. C., Quella, S. K., O'Fallon, J. R., Hatfield, A. K., Nelimark, R. A., Dose, A. M., Fischer, T., Johnson, C., Klatt, N. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408113310602 · Cited by 500
Non-genomic actions of androgens
Foradori, C. D., Weiser, M. J., & Handa, R. J. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.10.005 · Cited by 493
Review of the in Vivo Functions of the p160 Steroid Receptor Coactivator Family
Xu, J., & Li, Q. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0116 · Cited by 493
Sack, J. S., Kish, K. F., Wang, C., Attar, R. M., Kiefer, S. E., An, Y., Wu, G. Y., Scheffler, J. E., Salvati, M. E., Krystek, S. R., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081565498 · Cited by 491
Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer
Titus, M. A., Schell, M. J., Lih, F. B., Tomer, K. B., & Mohler, J. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0525 · Cited by 488
Wang, R.-S., Yeh, S., Tzeng, C., & Chang, C. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0025 · Cited by 487
The program of androgen-responsive genes in neoplastic prostate epithelium
Nelson, P. S., Clegg, N. J., Arnold, H., Ferguson, C., Bonham, M. J., White, J., Hood, L., & Lin, B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182376299 · Cited by 483
He, B., Kemppainen, J., & Wilson, E. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002807200 · Cited by 441
Ding, X. F., Anderson, C. M., Ma, H., Hong, H., Uht, R. M., Kushner, P. J., & Stallcup, M. R. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.2.0065 · Cited by 434
Jenster, G., van der Korput, H. A. G. M., Trapman, J., & Brinkmann, A. O. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7341 · Cited by 419
Structural basis of androgen receptor binding to selective androgen response elements
Shaffer, P. L., Jivan, A., Dollins, D. E., Claessens, F., & Gewirth, D. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401123101 · Cited by 400
He, B., Kemppainen, J., Voegel, J. J., Gronemeyer, H., & Wilson, E. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37219 · Cited by 372
Androgen Receptor Phosphorylation
Gioeli, D. G., Ficarro, S. B., Kwiek, J. J., Aaronson, D. S., Hancock, M., Catling, A. D., White, F. M., Christian, R. E., Settlage, R. E., Shabanowitz, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204131200 · Cited by 355
Molecular basis of androgen insensitivity
Brinkmann, A. O. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00466-x · Cited by 345
Nuclear receptor coregulators: multiple modes of modification.
Hermanson, O., Glass, C., & Rosenfeld, M. (2002) · Trends in endocrinology and metabolism · doi:10.1016/s1043-2760(01)00527-6 · Cited by 341
Zhou, Z. X., Sar, M., Simental, J. A., Lane, M. V., & Wilson, E. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36806-0 · Cited by 312
Biogenesis of caveolae: a structural model for caveolin-induced domain formation
Parton, R. G., Hanzal‐Bayer, M., & Hancock, J. F. (2006) · Journal of Cell Science · doi:10.1242/jcs.02853 · Cited by 302
Nuclear receptors: integration of multiple signalling pathways through phosphorylation
Rochette-Egly, C. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00115-8 · Cited by 291
Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.
Zhu, M.-L., & Kyprianou, N. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0084 · Cited by 286
A and B forms of the androgen receptor are expressed in a variety of human tissues
Wilson, C. M., & McPhaul, M. J. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(96)03819-1 · Cited by 267
From estrogen to androgen receptor: A new pathway for sex hormones in prostate
Yeh, S., Miyamoto, H., Shima, H., & Chang, C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5527 · Cited by 267
Murillo, H., Huang, H., Schmidt, L. J., Smith, D. I., & Tindall, D. J. (2001) · Endocrinology · doi:10.1210/endo.142.11.8467 · Cited by 263
Chmelar, R. S., Buchanan, G., Need, E. F., Tilley, W. D., & Greenberg, N. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.22365 · Cited by 260
Multiple Signal Input and Output Domains of the 160-Kilodalton Nuclear Receptor Coactivator Proteins
Ma, H., Hong, H., Huang, S.-M., Irvine, R. A., Webb, P., Kushner, P. J., Coetzee, G. A., & Stallcup, M. R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6164 · Cited by 256
Platz, E. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.24.2009 · Cited by 252
Caveolin-1 Interacts with Androgen Receptor
Lu, M. L., Schneider, M. C., Zheng, Y., Zhang, X., & Richie, J. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006598200 · Cited by 239
Recognition and Accommodation at the Androgen Receptor Coactivator Binding Interface
Hur, E., Pfaff, S. J., Payne, E. S., Grøn, H., Buehrer, B. M., & Fletterick, R. J. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020274 · Cited by 234
Unni, E., Sun, S., Nan, B., McPhaul, M. J., Cheskis, B. J., Mancini, M. A., & Marcelli, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1121 · Cited by 233
Diverse roles of androgen receptor (AR) domains in AR-mediated signaling
Claessens, F., Denayer, S., Tilborgh, N. V., Kerkhofs, S., Helsen, C., & Haelens, A. (2008) · Nuclear Receptor Signaling · doi:10.1621/nrs.06008 · Cited by 232
Dillard, P., Lin, M., & Khan, S. A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.013 · Cited by 225
Growth factor involvement in progression of prostate cancer
Russell, P. J., Bennett, S., & Stricker, P. D. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.4.705 · Cited by 223
Structural basis for the nuclear import of the human androgen receptor
Cutress, M. L., Whitaker, H. C., Mills, I. G., Stewart, M., & Neal, D. E. (2008) · Journal of Cell Science · doi:10.1242/jcs.022103 · Cited by 219
STRUM, S. B., McDERMED, J. E., SCHOLZ, M. C., JOHNSON, H., & TISMAN, G. (1997) · British Journal of Urology · doi:10.1046/j.1464-410x.1997.00234.x · Cited by 215
Sircar, K., Yoshimoto, M., Monzon, F. A., Koumakpayi, I. H., Katz, R. L., Khanna, A., Alvarez, K., Chen, G., Darnel, A. D., Aprikian, A. G., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2559 · Cited by 213
Schaufele, F., Carbonell, X., Guerbadot, M., Borngraeber, S., Chapman, M. S., Ma, A. A. K., Miner, J. N., & Diamond, M. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408819102 · Cited by 208
Regulation of Androgen Receptor Activity by the Nuclear Receptor Corepressor SMRT*
Liao, G., Chen, L.-Y., Zhang, A., Godavarthy, A., Xia, F., Ghosh, J. C., Li, H., & Chen, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206374200 · Cited by 207
Miyamoto, H., Yeh, S., Wilding, G., & Chang, C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7379 · Cited by 203
Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions
Loy, C. J., Sim, K. S., & Yong, E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0736237100 · Cited by 202
Mutation of the androgen receptor causes oncogenic transformation of the prostate.
Han, G., Buchanan, G., Ittmann, M., Harris, J. M., Yu, X., DeMayo, F. J., Tilley, W., & Greenberg, N. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408925102 · Cited by 192
Expression and Degradation of Androgen Receptor: Mechanism and Clinical Implication
Lee, D., & Chang, C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030261 · Cited by 184
Kutscher, W., & Wolbergs, H. (1935) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1935.236.4-6.237 · Cited by 184
Mechanism of androgen receptor action
Li, J., & Al‐Azzawi, F. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.03.008 · Cited by 182
Treatment of Prostate Cancer with Gonadotropin-Releasing Hormone Agonists
Labrie, F., Dupont, A., Bèlanger, A., St‐Arnaud, R., Giguère, M., Lacourcière, Y., Emond, J., & Monfette, G. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-1-67 · Cited by 179
Baron, S., Manin, M., Beaudoin, C., Léotoing, L., Communal, Y., VEYSSIERE, G., & Morel, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306143200 · Cited by 178
Rajput, A. B., Miller, M. A., Luca, A. D., et al. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.043810 · Cited by 175
Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation
Gaughan, L. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki141 · Cited by 174
Compartmentalization of androgen receptor protein–protein interactions in living cells
van Royen, M. E., Cunha, S. M. P. R. M., Brink, M. C., Mattern, K. A., Nigg, A. L., Dubbink, H. J., Verschure, P. J., Trapman, J., & Houtsmuller, A. B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200609178 · Cited by 170
Song, L.-N., Herrell, R., Byers, S., Shah, S., Wilson, E. M., & Gelmann, E. P. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.5.1674-1687.2003 · Cited by 169
Dependence of Selective Gene Activation on the Androgen Receptor NH2- and COOH-terminal Interaction
He, B., Lee, L. W., Minges, J. T., & Wilson, E. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202809200 · Cited by 168
Identification and Characterization of a Ligand-regulated Nuclear Export Signal in Androgen Receptor
Saporita, A. J., Zhang, Q., Navai, N., Dincer, Z., Hahn, J., Cai, X., & Wang, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302460200 · Cited by 167
Androgen Receptor Nuclear Translocation Is Facilitated by the f-Actin Cross-Linking Protein Filamin
Ozanne, D. M., Brady, M. E., Cook, S., Gaughan, L., Neal, D. E., & Robson, C. N. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.10.0541 · Cited by 162
Schoenmakers, E., Alen, P., Verrijdt, G., Peeters, B., Verhoeven, G., Rombauts, W., & Claessens, F. (1999) · Biochemical Journal · doi:10.1042/bj3410515 · Cited by 158
McEwan, I. J. (2004) · Endocrine-related cancer · doi:10.1677/erc.0.0110281 · Cited by 156
Haelens, A., Tanner, T., Denayer, S., Callewaert, L., & Claessens, F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1701 · Cited by 153
Verrijdt, G. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00003-9 · Cited by 148
Centenera, M. M., Harris, J. M., Tilley, W. D., & Butler, L. M. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0017 · Cited by 146
Control of histone modifications
Davie, J., & Spencer, V. A. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1999)75:32+ · Cited by 146
Classical androgen receptors in non-classical sites in the brain
Sarkey, S., Azcoitia, I., Garcia-Segura, L. M., Garcia-Ovejero, D., & DonCarlos, L. L. (2008) · Hormones and Behavior · doi:10.1016/j.yhbeh.2008.02.015 · Cited by 146
Infancy is not a quiescent period of testicular development
Chemes, H. E. (2001) · International Journal of Andrology · doi:10.1046/j.1365-2605.2001.00260.x · Cited by 142
Trinucleotide repeats in the human androgen receptor: a molecular basis for disease
Choong, C. S., & Em, W. (1998) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0210235 · Cited by 141
Caveolae, transmembrane signalling and cellular transformation
Lisanti, M. P., Tang, Z., Scherer, P. E., et al. (1995) · Molecular Membrane Biology · doi:10.3109/09687689509038506 · Cited by 140
Veldscholte, J., Berrevoets, C. A., Zegers, N. D., Van der Kwast, T. H., Grootegoed, J. A., & Mulder, E. (1992) · Biochemistry · doi:10.1021/bi00147a029 · Cited by 139
Assembly of the SMRT–histone deacetylase 3 repression complex requires the TCP-1 ring complex
Guenther, M. G., Yu, J., Kao, G. D., Yen, T. J., & Lazar, M. A. (2002) · Genes & Development · doi:10.1101/gad.1037502 · Cited by 138
Ligand-Specific Dynamics of the Androgen Receptor at Its Response Element in Living Cells
Klokk, T. I., Kurys, P., Elbi, C., Nagaich, A. K., Hendarwanto, A., Slagsvold, T., Chang, C., Hager, G. L., & Saatcioglu, F. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01297-06 · Cited by 132
Androgen cell signaling pathways involved in neuroprotective actions
Pike, C. J., Nguyen, T. V., Ramsden, M., Yao, M., Murphy, M. P., & Rosario, E. R. (2007) · Hormones and Behavior · doi:10.1016/j.yhbeh.2007.11.006 · Cited by 132
Genomic Strategy for Targeting Therapy in Castration-Resistant Prostate Cancer
Mendiratta, P., Mostaghel, E. A., Guinney, J., Tewari, A. K., Porrello, A., Barry, W. T., Nelson, P. S., & Febbo, P. G. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2882 · Cited by 127
The role of the polyglutamine tract in androgen receptor
Palazzolo, I., Gliozzi, A., Rusmini, P., Sau, D., Crippa, V., Simonini, F., Onesto, E., Bolzoni, E., & Poletti, A. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.09.016 · Cited by 123
Molecular Biology of the Androgen Receptor: From Molecular Understanding to the Clinic
Eder, I. E., Čulig, Z., Putz, T., Nessler‐Menardi, C., Bartsch, G. H., & Klocker, H. (2001) · European Urology · doi:10.1159/000049782 · Cited by 122
Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor.
Cheng, S., Brzostek, S., Lee, S. R., Hollenberg, A. N., & Balk, S. P. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.7.0870 · Cited by 121
Androgen receptor corepressors: An overview
Wang, L., Hsu, C., & Chang, C. (2004) · The Prostate · doi:10.1002/pros.20170 · Cited by 115
Antiandrogens prevent stable DNA-binding of the androgen receptor
Farla, P., Hersmus, R., Trapman, J., & Houtsmuller, A. B. (2005) · Journal of Cell Science · doi:10.1242/jcs.02546 · Cited by 114
Inhibiting Proteasomes in Human HepG2 and LNCaP Cells Increases Endogenous Androgen Receptor Levels
Sheflin, L. G., Keegan, B. P., Zhang, W., & Spaulding, S. W. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3424 · Cited by 114
CYP17 inhibition as a hormonal strategy for prostate cancer
Reid, A. H. M., Attard, G., Barrie, E., & Bono, J. S. D. (2008) · Nature Clinical Practice Urology · doi:10.1038/ncpuro1237 · Cited by 114
Chamberlain, N. L., Whitacre, D. C., & Miesfeld, R. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26772 · Cited by 113
Zitzmann, M., Depenbusch, M., Gromoll, J., & Nieschlag, E. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021947 · Cited by 112
Interplay between two hormone-independent activation domains in the androgen receptor.
Callewaert, L., Van Tilborgh, N., & Claessens, F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2389 · Cited by 111
Manin, M., Baron, S., Goossens, K., Beaudoin, C., Jean, C., VEYSSIERE, G., Verhoeven, G., & Morel, L. (2002) · Biochemical Journal · doi:10.1042/bj20020585 · Cited by 107
Cardozo, C. P., Michaud, C., Ost, M. C., Fliss, A., Yang, E., Patterson, C., Hall, S. J., & Caplan, A. J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00680-x · Cited by 106
Androgen Receptor Coregulators in Prostate Cancer
Rahman, M. M., Miyamoto, H., & Chang, C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0746-3 · Cited by 103
Effect of a short CAG (glutamine) repeat on human androgen receptor function
Ding, D., Xu, L., Menon, M., Reddy, G. P. V., & Barrack, E. R. (2003) · The Prostate · doi:10.1002/pros.10316 · Cited by 99
Cao, X., Qin, J., Xie, Y., Khan, O. Y., Dowd, F. J., Scofield, M., Lin, M.-F., & Tu, Y. (2006) · Oncogene · doi:10.1038/sj.onc.1209408 · Cited by 99
Lee, Y., Shyr, C., Thin, T. H., Lin, W., & Chang, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14724 · Cited by 98
Cinar, B., Mukhopadhyay, N. K., Meng, G., & Freeman, M. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703310200 · Cited by 92
Complications of androgen deprivation therapy for prostate cancer
Holzbeierlein, J. M., McLaughlin, M. D., & Thrasher, J. B. (2004) · Current Opinion in Urology · doi:10.1097/00042307-200405000-00007 · Cited by 92
The androgen receptor gene and its influence on the development and progression of prostate cancer
Montgomery, J. S., Price, D. K., & Figg, W. D. (2001) · The Journal of Pathology · doi:10.1002/1096-9896(200109)195:2 · Cited by 92
Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.
Powell, S. M., Christiaens, V., Voulgaraki, D., Waxman, J., Claessens, F., & Bevan, C. L. (2004) · Endocrine Related Cancer · doi:10.1677/erc.0.0110117 · Cited by 90
Hong, H., Darimont, B. D., Ma, H., Yang, L., Yamamoto, K. R., & Stallcup, M. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3496 · Cited by 89
Forskolin-Induced Dephosphorylation of the Androgen Receptor Impairs Ligand Binding
Blok, L. J., de Ruiter, P. E., & Brinkmann, A. O. (1998) · Biochemistry · doi:10.1021/bi9724422 · Cited by 86
Dehm, S. M., Regan, K. M., Schmidt, L. J., & Tindall, D. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1267 · Cited by 84
Androgen receptor corepressors and prostate cancer
Burd, C. J., Morey, L. M., & Knudsen, K. E. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01115 · Cited by 83
Early Metazoan Divergence Was About 830 Million Years Ago
Gu, X. (1998) · Journal of Molecular Evolution · doi:10.1007/pl00013150 · Cited by 82
Wang, Y., Kreisberg, J. I., Bedolla, R. G., Михайлова, М. А., White, R. D., & Ghosh, P. (2007) · Oncogene · doi:10.1038/sj.onc.1210435 · Cited by 81
Christiaens, V., Bevan, C. L., Callewaert, L., Haelens, A., Verrijdt, G., Rombauts, W., & Claessens, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209322200 · Cited by 79
Shatkina, L., Mink, S., Rogatsch, H., Klocker, H., Langer, G., Nestl, A., & Cato, A. C. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7189-7197.2003 · Cited by 78
Androgen receptor knockout and knock-in mouse models
Kerkhofs, S., Denayer, S., Haelens, A., & Claessens, F. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0122 · Cited by 75
Yuan, X., Li, T., Wang, H., Zhang, T., Barua, M., Borgesi, R. A., Bubley, G. J., Lu, M. L., & Balk, S. P. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051047 · Cited by 75
Androgen receptor CAG polymorphism and prostate cancer risk
Mononen, N., Ikonen, T., Autio, V., Rökman, A., Matikainen, M. P., Tammela, T. L. J., Kallioniemi, O., Koivisto, P. A., & Schleutker, J. (2002) · Human Genetics · doi:10.1007/s00439-002-0776-5 · Cited by 74
Androgen Receptors in the Brain: What Are We Measuring?*
Sheridan, P. J. (1983) · Endocrine Reviews · doi:10.1210/edrv-4-2-171 · Cited by 73
Vertebrate Sex Steroid Receptors: Evolution, Ligands, and Neurodistribution
Guerriero, G. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04460.x · Cited by 68
Wiren, K. M., Semirale, A. A., Zhang, X.-W., Woo, A., Tommasini, S. M., Price, C., Schaffler, M. B., & Jepsen, K. J. (2008) · Bone · doi:10.1016/j.bone.2008.04.026 · Cited by 65
Papadopoulou, N., Papakonstanti, E. A., Kallergi, G., Alevizopoulos, K., & Stournaras, C. (2008) · IUBMB Life · doi:10.1002/iub.150 · Cited by 63
Robinson, J. N., GUTMAN, E. B., & Gutman, A. B. (1939) · The Journal of Urology · doi:10.1016/s0022-5347(17)71556-x · Cited by 60
Lange, E. M., Sarma, A. V., Ray, A. M., Wang, Y., Ho, L. A., Anderson, S. A., Cunningham, J. M., & Cooney, K. A. (2008) · Journal of Human Genetics · doi:10.1007/s10038-007-0240-4 · Cited by 55
Age‐related changes in hypothalamic androgen receptor and estrogen receptor α in male rats
Wu, D., Lin, G. R., & Gore, A. C. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21925 · Cited by 52
Phylogeny of the Steroid Receptor Superfamily
Detera‐Wadleigh, S. D., & Fanning, T. G. (1994) · Molecular Phylogenetics and Evolution · doi:10.1006/mpev.1994.1022 · Cited by 49
Androgens, ApoE, and Alzheimer's Disease
Raber, J. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.11.re2 · Cited by 48
CASTAGNETTA, L. A. M., Carruba, G., Traina, A., Granata, O. M., Markus, M., Pavone‐Macaluso, M., Blomquist, C. H., & Adamski, J. (1997) · Endocrinology · doi:10.1210/endo.138.11.5497 · Cited by 47
Rizk‐Jackson, A., Robertson, J., & Raber, J. (2005) · Brain Research · doi:10.1016/j.brainres.2004.12.002 · Cited by 47
Bonaccorsi, L. (2004) · Steroids · doi:10.1016/j.steroids.2004.05.011 · Cited by 44
The Androgen Receptor: Unlocking the Secrets of Its Unique Transactivation Domain
Shen, H. C., & Coetzee, G. A. (2005) · Vitamins and hormones · doi:10.1016/s0083-6729(05)71010-4 · Cited by 44
Wang, M., Wang, Y., Abarbanell, A. M., Tan, J., Weil, B. R., Herrmann, J. L., & Meldrum, D. R. (2009) · Surgery · doi:10.1016/j.surg.2009.03.035 · Cited by 37
GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor
Shen, H. C., Buchanan, G., Butler, L. M., et al. (2005) · Biological Chemistry · doi:10.1515/bc.2005.009 · Cited by 37
Study of Androgen Receptor Functions by Genetic Models
Μatsumoto, T., Takeyama, K., Sato, T., & Kato, S. (2005) · The Journal of Biochemistry · doi:10.1093/jb/mvi118 · Cited by 36
Determinants for DNA-binding site recognition by the glucocorticoid receptor.
Zilliacus, J., Wright, A. P. H., Norinder, U., Gustafsson, J.-Α., & Carlstedt‐Duke, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)73988-x · Cited by 36
Androgen receptor and caveolin‐1 in prostate cancer
Bennett, N. J., Hooper, J. D., Lee, C. S., & Gobe, G. C. (2009) · IUBMB Life · doi:10.1002/iub.244 · Cited by 30
Self-citationReid, J., Betney, R., Watt, K., & McEwan, I. J. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311042 · Cited by 29
Reflections on the Diseases Linked to Mutations of the Androgen Receptor
Poletti, A., Negri‐Cesi, P., & Martini, L. (2005) · Endocrine · doi:10.1385/endo:28:3:243 · Cited by 28
Handratta, V. D., Jelovac, D., Long, B. J., et al. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.07.006 · Cited by 24
Testosterone replacement therapy and prostate cancer: A word of caution
Brand, T. C., Canby‐Hagino, E., & Thompson, I. M. (2007) · Current Urology Reports · doi:10.1007/s11934-007-0004-x · Cited by 21
5-alpha-reductase and the development of the human prostate
Radmayr, C., Lunacek, A., Schwentner, C., et al. (2008) · Indian Journal of Urology · doi:10.4103/0970-1591.42610 · Cited by 19
Androgen receptor CAG repeat length contraction in diseased and non-diseased prostatic tissues
Sircar, K., Gottlieb, B., Alvarado, C., Aprikian, A. G., Beitel, L. K., Alam‐Fahmy, M., Bégin, L. R., & Trifiro, M. A. (2007) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500967 · Cited by 19
Chang, H. M. A. C. (2000) · International Journal of Urology · doi:10.1046/j.1442-2042.2000.00129.x · Cited by 17
Androgens, ageing and vascular function
Getov, S., Lee, R., Dockery, F., & Rajkumar, C. (2008) · Age and Ageing · doi:10.1093/ageing/afn125 · Cited by 3
Maximum androgen blockade: a case study report
Newling, D., & for the Maximum Androgen Blockade Case Study Group (2000) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500425 · Cited by 2
Androgen-mediated apoptosis of kidney tubule cells: role of c-Jun amino terminal kinase.
Verzola, D., Villaggio, B., Procopio, V., et al. (2009) · PubMed · doi:10.1016/j.bbrc.2009.07.056
Ware (2004) · Expert Rev Proteomics · doi:10.1586/14789450.1.4.485
UnresolvedMutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone
Culig (1993) · Mol Endocrinol
UnresolvedAndrogen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor
Culig (1994) · Cancer Res
UnresolvedDifferential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers
Glass (1994) · Endocr Rev
UnresolvedGottlieb DB. The androgen receptor gene mutations database world wide web server. Retrieved 27/9/09, from http://androgendb.mcgill.ca/; 2008.
(n.d.)
UnresolvedPhylogeny of vertebrate nuclear receptors—analysis of variance components in protein sequences
Gurel (2003) · Coll Antropol
UnresolvedStudies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate
Huggins (1941) · Cancer Res
UnresolvedAndrogen receptor gene alterations and chromosomal gains and losses in prostate carcinomas appearing during finasteride treatment for benign prostatic hyperplasia
Koivisto (1999) · Clin Cancer Res
UnresolvedNongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity
Kousteni (2001) · Cell
UnresolvedAbnormal Leydig cell development at puberty in the androgen-resistant Tfm mouse
Murphy (1994) · Endocrinology
UnresolvedMutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence
Tilley (1996) · Clin Cancer Res
UnresolvedHER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway
Wen (2000) · Cancer Res
UnresolvedCholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells
Zhuang (2002) · Cancer Res
Unresolved
Cited by
Sorted by citations
Heck, A., & Handa, R. J. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0167-9 · Cited by 567
Sex differences in anxiety and depression: Role of testosterone
McHenry, J. A., Carrier, N., Hull, E. M., & Kabbaj, M. (2013) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.09.001 · Cited by 526
“More detailed information regarding the molecular mechanisms of androgens and estrogens at their receptors can be found in Bennett et al. (2010).”
BackgroundSex differences and sex steroids in lung health and disease
Townsend, E. A., Miller, V. M., & Prakash, Y. S. (2012) · Endocrine Reviews · doi:10.1210/er.2010-0031 · Cited by 395
Androgen-Induced Immunosuppression
Bupp, M. G., & Jørgensen, T. N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00794 · Cited by 404
“Activation of non-classical (NC) AR rapidly affects the regulation of other nuclear receptors, transcription factors, and cytoplasmic signaling events including the release of intracellular calcium and the formation of inositol 1,4,5-triphosphate (15).”
BackgroundSex, the aging immune system, and chronic disease
Bupp, M. G. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.02.002 · Cited by 333
“Peripheral T and B cells, thymocytes, bone marrow stromal cells, thymic epithelial cells, macrophages, monocytes, dendritic cells, and mast cells express intracellular androgen receptors and peripheral T cells and circulating monocytes also express membrane-bound ARs [45–48].”
Background
Metadata
- Authors
- Bennett, N. C., Gardiner, R. A., Hooper, J. D., Johnson, D. W., & Gobe, G. C.
- Affiliations
- The University of Queensland (AU)
- Queensland University of Technology (AU)
- Princess Alexandra Hospital (AU)
- Corresponding author
- Gobe, Glenda C.
- Venue
- The International Journal of Biochemistry & Cell Biology
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 42
- Issue
- 6
- Pages
- 813-827
- ISSN
- 1357-2725 (ISSN-L)
- OpenAlex
- W1546185806
- Cited by
- 292
- References
- 172
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 16 · 2023: 18 · 2022: 24 · 2021: 22 · 2020: 23 · 2019: 17 · 2018: 22 · 2017: 15 · 2016: 13 · 2015: 30 · 2014: 15 · 2013: 22 · 2012: 18
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- The International Journal of Biochemistry & Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Faculty of Health; Institute of Health and Biomedical Innovation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- androgen receptor, androgen signaling, nuclear translocation, transcriptional regulation, transcription factor crosstalk, androgen insensitivity syndrome, prostate cancer, androgen deprivation therapy, androgen receptor mutations
- MeSH terms
- Animals, Humans, Male, Polymorphism, Genetic, Prostatic Neoplasms, Receptors, Androgen, Gonadal Steroid Hormones, Androgen-Insensitivity Syndrome, Transcription Factors, Signal Transduction, Transcriptional Activation, Genetic Predisposition to Disease, Multiprotein Complexes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review